{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:40:57Z","timestamp":1787625657966,"version":"build-2736575974"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Uterine corpus cancer (UCC) demonstrates significant global heterogeneity in incidence patterns, with aggressive histological subtypes contributing disproportionately to mortality despite their lower prevalence. Current understanding of temporal trends and geographical variations in subtype distribution remains fragmented, particularly in low- and middle-income countries (LMICs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This population-based study analyzed Cancer Incidence in Five Continents (CI5) data (volumes I\u2013XII, 1988\u20132017) from 65 countries across all development levels. Age-standardized incidence rates (ASRs) were calculated by histological subtype (endometrioid, serous, clear cell, carcinosarcoma, other specified, and unspecified) and evaluated using joinpoint regression for temporal trends and geospatial mapping for regional patterns. Subtype distributions were analyzed by Sociodemographic Index (SDI) level and age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Three key findings emerged: (1) Distinct geographical patterns with Eastern Europe showing peak historical rates (Czech Republic ASR 31.16) now declining (\u221234%), while Asia demonstrates rapid increases (Japan\u00a0+\u00a037%, South Korea\u00a0+\u00a0188%); (2) Strong socioeconomic gradients with adenocarcinoma comprising 84% of cases in high-SDI countries versus predominance of unspecified types (\u226430%) in low-SDI regions; (3) Characteristic age distributions peaking at 65\u201369\u00a0years (ASR 54.54) with elderly populations showing disproportionately high unspecified cases (28\u201335%). Temporal analysis revealed accelerating trends in aggressive subtypes (serous carcinoma\u00a0+\u00a01.8%\/year in North America), contrasting with stable endometrioid rates in most regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study highlights the evolving global epidemiology of UCC by histological subtype, emphasizing how development level influences disease patterns and diagnostic capacity. The findings underscore the urgent need for subtype-specific prevention strategies and improved pathological infrastructure to address global disparities in uterine cancer burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004353","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:00:53Z","timestamp":1765458053000},"page":"7661-7683","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Global trends and disparities in uterine corpus cancer by histological subtype: a population-based analysis"],"prefix":"10.1097","volume":"112","author":[{"given":"Quan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Shengli Clinical Medical College, Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China"},{"name":"Department of Obstetrics and Gynecology, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian Province, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Qinghai Provincial People\u2019s Hospital, Xining, Qinghai Province, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Shengli Clinical Medical College, Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China"},{"name":"Department of Obstetrics and Gynecology, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian Province, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Feng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, The 900th Hospital of Joint Logistic Support Force, PLA, Fuzhou, Fujian Province, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s41043-025-00915-1","article-title":"Global, regional, and national burden of uterine cancer among women aged 50 years and older from 1990 to 2021: a systematic analysis for the global burden of disease study 2021","volume":"44","author":"Feng","year":"2025","journal-title":"J Health Popul Nutr"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1097\/JS9.0000000000002883","article-title":"Causal impact of obesity class stratification and endometrial cancer subtypes: an integrated mendelian randomization and global burden of disease study 2021 analysis","volume":"111","author":"Tong","year":"2025","journal-title":"Int J Surg"},{"key":"R3-20260417","doi-asserted-by":"crossref","first-page":"e000647","DOI":"10.20945\/2359-3997000000647","article-title":"Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions","volume":"67","author":"de Andrade Mesquita","year":"2023","journal-title":"Arch Endocrinol Metab"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"1139\u201344","DOI":"10.1007\/s00404-011-2116-2","article-title":"Obesity and perioperative outcomes in endometrial cancer surgery","volume":"285","author":"Santoso","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R5-20260417","first-page":"2190\u2013201","article-title":"Burden of female breast and five gynecological cancers in China and worldwide","volume":"137","author":"Tan","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R6-20260417","doi-asserted-by":"crossref","first-page":"781\u201387","DOI":"10.1016\/j.soard.2023.01.029","article-title":"Obesity, metabolic and bariatric surgery, and cancer prevention: what do we need to learn and how do we get there?","volume":"19","author":"Sauter","year":"2023","journal-title":"Surg Obes Relat Dis"},{"key":"R7-20260417","doi-asserted-by":"crossref","first-page":"103213","DOI":"10.1016\/j.eclinm.2025.103213","article-title":"Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study","volume":"83","author":"Wolff Sagy","year":"2025","journal-title":"EClinicalMedicine"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"189000","DOI":"10.1016\/j.bbcan.2023.189000","article-title":"The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches","volume":"1878","author":"Burkett","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"891\u2013903","DOI":"10.1097\/JS9.0000000000001956","article-title":"Global burden and trends in pre- and post-menopausal gynecological cancer from 1990 to 2019, with projections to 2040: a cross-sectional study","volume":"111","author":"Liang","year":"2025","journal-title":"Int J Surg"},{"key":"R10-20260417","first-page":"67\u201373","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"2067\u201373","DOI":"10.1007\/s12253-020-00829-9","article-title":"TCGA classification of endometrial cancer: the place of carcinosarcoma","volume":"26","author":"Travaglino","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"94\u2013103","DOI":"10.1016\/j.ygyno.2024.04.008","article-title":"Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): a critical reappraisal with comments on FIGO 2023 staging","volume":"186","author":"Espinosa","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"963\u201372","DOI":"10.1007\/s00066-020-01632-w","article-title":"The brave new world of endometrial cancer: future implications for adjuvant treatment decisions","volume":"196","author":"Marnitz","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"R14-20260417","doi-asserted-by":"crossref","first-page":"13\u201320","DOI":"10.1002\/ijgo.13937","article-title":"Prognostic value of the TCGA molecular classification in uterine carcinosarcoma","volume":"158","author":"Travaglino","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"R15-20260417","doi-asserted-by":"crossref","first-page":"2833\u201341","DOI":"10.1007\/s00404-024-07504-3","article-title":"Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe","volume":"309","author":"Kelkar","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"976\u201385","DOI":"10.1111\/his.12096","article-title":"ER+ \/PR+ \/TFF3+ \/IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases","volume":"62","author":"Mhawech-Fauceglia","year":"2013","journal-title":"Histopathology"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"101251","DOI":"10.1016\/j.gore.2023.101251","article-title":"Low-level expression of human Epidermal growth Factor Receptor-2 (HER2) in high-grade mullerian tumors: implications for therapy decision making","volume":"49","author":"Abada","year":"2023","journal-title":"Gynecol Oncol Rep"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/healthcare9070902","article-title":"Tumor characteristic variations between symptomatic and asymptomatic endometrial cancer","volume":"9","author":"Vinklerova","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"625\u201334","DOI":"10.1007\/s12094-022-02799-7","article-title":"SEOM-GEICO clinical guidelines on endometrial cancer (2021)","volume":"24","author":"Barretina-Ginesta","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"R20-20260417","doi-asserted-by":"crossref","first-page":"210\u201320","DOI":"10.1016\/j.ygyno.2023.01.024","article-title":"Risk stratification and molecular heterogeneity of endometrial cancer and expression profile of TIM-3: a retrospective cohort study","volume":"170","author":"Zhang","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R21-20260417","doi-asserted-by":"crossref","first-page":"895\u2013903","DOI":"10.1001\/jamaoncol.2022.0009","article-title":"Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype","volume":"8","author":"Clarke","year":"2022","journal-title":"JAMA Oncol"},{"key":"R22-20260417","doi-asserted-by":"crossref","first-page":"998\u20131009","DOI":"10.1002\/ijgo.14780","article-title":"Global incidence and mortality trends of corpus uteri cancer and associations with gross domestic product, human development index, lifestyle, and metabolic risk factors","volume":"162","author":"Huang","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R23-20260417","doi-asserted-by":"crossref","first-page":"762\u201378","DOI":"10.1111\/his.14609","article-title":"Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)","volume":"80","author":"McCluggage","year":"2022","journal-title":"Histopathology"},{"key":"R24-20260417","doi-asserted-by":"crossref","first-page":"444\u201357","DOI":"10.1158\/1055-9965.EPI-16-0858","article-title":"Global cancer in women: burden and trends","volume":"26","author":"Torre","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R25-20260417","doi-asserted-by":"crossref","first-page":"219\u201330","DOI":"10.1093\/jncimonographs\/lgad021","article-title":"Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program","volume":"2023","author":"Sereda","year":"2023","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R28-20260417","first-page":"100081","article-title":"Revised Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of Artificial Intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R29-20260417","doi-asserted-by":"crossref","first-page":"36\u201346","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol"},{"key":"R30-20260417","doi-asserted-by":"crossref","first-page":"354\u201361","DOI":"10.1093\/jnci\/djx214","article-title":"International patterns and trends in endometrial cancer incidence, 1978-2013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R31-20260417","first-page":"1160\u2013203","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Collaborators","year":"2020","journal-title":"Lancet"},{"key":"R32-20260417","first-page":"1223\u201349","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R33-20260417","doi-asserted-by":"crossref","first-page":"383\u201394","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R34-20260417","doi-asserted-by":"crossref","first-page":"4215\u201324","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R35-20260417","doi-asserted-by":"crossref","first-page":"335\u201351","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R36-20260417","doi-asserted-by":"crossref","first-page":"3670\u201382","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"R37-20260417","first-page":"20\u201325","article-title":"Segmented: an R package to fit regression models with broken-line relationships","volume":"8","author":"Vm","year":"2008","journal-title":"R News"},{"key":"R38-20260417","doi-asserted-by":"crossref","first-page":"1719\u201330","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer: an umbrella review of the literature","volume":"145","author":"Raglan","year":"2019","journal-title":"Int J Cancer"},{"key":"R39-20260417","doi-asserted-by":"crossref","first-page":"1412\u201328","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"R40-20260417","doi-asserted-by":"crossref","first-page":"778\u201389","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"R41-20260417","doi-asserted-by":"crossref","first-page":"174\u201382","DOI":"10.3802\/jgo.2014.25.3.174","article-title":"Trends in gynecologic cancer mortality in East Asian regions","volume":"25","author":"Lee","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"R42-20260417","doi-asserted-by":"crossref","first-page":"49\u201358","DOI":"10.1002\/ijc.31664","article-title":"Global cancer incidence in older adults, 2012 and 2035: a population-based study","volume":"144","author":"Pilleron","year":"2019","journal-title":"Int J Cancer"},{"key":"R43-20260417","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13027-017-0124-y","article-title":"An update on the management of breast cancer in Africa","volume":"12","author":"Vanderpuye","year":"2017","journal-title":"Infect Agent Cancer"},{"key":"R44-20260417","doi-asserted-by":"crossref","first-page":"218e1","DOI":"10.1016\/j.ajog.2007.08.075","article-title":"Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths","volume":"198","author":"Ueda","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R45-20260417","doi-asserted-by":"crossref","first-page":"2607\u201318","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol"},{"key":"R46-20260417","doi-asserted-by":"crossref","first-page":"1023\u201375","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"R47-20260417","doi-asserted-by":"crossref","first-page":"417\u201326","DOI":"10.1002\/ijc.27623","article-title":"Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?","volume":"132","author":"Trabert","year":"2013","journal-title":"Int J Cancer"},{"key":"R48-20260417","doi-asserted-by":"crossref","first-page":"470\u201376","DOI":"10.1016\/j.ygyno.2021.02.037","article-title":"Racial disparities in high-risk uterine cancer histologic subtypes: a United States Cancer Statistics study","volume":"161","author":"Abel","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R49-20260417","first-page":"47\u201383","article-title":"Kinetics of disposition of xenobiotics and their metabolites","volume":"6","author":"Houston","year":"1988","journal-title":"Drug Metabol Drug Interact"},{"key":"R50-20260417","doi-asserted-by":"crossref","first-page":"651\u201362","DOI":"10.2147\/IJWH.S499435","article-title":"Global trends in incidence and mortality rates of endometrial cancer among individuals aged 55 years and above from 1990 to 2021: an analysis of the global burden of disease","volume":"17","author":"Gao","year":"2025","journal-title":"Int J Womens Health"},{"key":"R51-20260417","doi-asserted-by":"crossref","first-page":"1594\u2013604","DOI":"10.1038\/modpathol.2013.102","article-title":"Reproducibility of histological cell type in high-grade endometrial carcinoma","volume":"26","author":"Han","year":"2013","journal-title":"Mod Pathol"},{"key":"R52-20260417","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R53-20260417","doi-asserted-by":"crossref","first-page":"102983","DOI":"10.1016\/j.eclinm.2024.102983","article-title":"Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017","volume":"79","author":"Wei","year":"2025","journal-title":"EClinicalMedicine"},{"key":"R54-20260417","doi-asserted-by":"crossref","first-page":"10\u201317","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"R55-20260417","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"Bmj"},{"key":"R56-20260417","first-page":"1201\u201311","article-title":"Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women\u2019s Health Initiative Observational Study","volume":"30","author":"Trabert","year":"2019","journal-title":"Cancer Causes Control"},{"key":"R57-20260417","doi-asserted-by":"crossref","first-page":"28\u201332","DOI":"10.5858\/1999-123-0028-PFTEOS","article-title":"Protocol for the examination of specimens from patients with carcinomas of the endometrium: a basis for checklists. Cancer Committee, College of American Pathologists","volume":"123","author":"Silverberg","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"R58-20260417","doi-asserted-by":"crossref","first-page":"99\u2013108","DOI":"10.1016\/j.ctrv.2016.08.007","article-title":"Improving outcomes for older women with gynaecological malignancies","volume":"50","author":"Dumas","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"R59-20260417","doi-asserted-by":"crossref","first-page":"12\u201339","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R60-20260417","doi-asserted-by":"crossref","first-page":"152366","DOI":"10.1016\/j.aanat.2024.152366","article-title":"Exploring the potential and limitations of artificial intelligence in animal anatomy","volume":"258","author":"Choudhary","year":"2025","journal-title":"Ann Anat"},{"key":"R61-20260417","first-page":"4090\u201395","article-title":"Animal models for surgeries and implants: a vital tool in medical research and development","volume":"87","author":"Choudhary","year":"2025","journal-title":"Ann Med Surg Lond"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:01:22Z","timestamp":1776423682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004353","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"2025-08-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}